Printer Friendly
The Free Library
14,757,922 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Tamoxifen dilates arteries in men.


The breast cancer drug tamoxifen tamoxifen (təmŏk`sĭfĕn'), synthetic hormone used in the treatment of breast cancer. Introduced in 1978, tamoxifen is used to prevent recurrences of cancer in women who have already undergone surgery to remove their tumors.  can widen a narrowed coronary artery coronary artery
n.
1. An artery with origin in the right aortic sinus; with distribution to the right side of the heart in the coronary sulcus, and with branches to the right atrium and ventricle, including the atrioventricular branches and
 in men with heart problems, a new study shows. Although the test population comprised only a few dozen participants, the study suggests that the drug may play a valuable role beyond fighting cancer.

Researchers gave tamoxifen orally for 56 days to 16 men--average age 61--with heart disease. Fifteen other men in similar health--average age 64--received an inactive pill. All these volunteers were taking aspirin and cholesterol-lowering drugs called statins Statins
A class of drugs commonly used to lower LDL cholesterol levels.

Mentioned in: C-Reactive Protein
. Ten other men without severe heart disease but with chest pain called angina Angina Definition

Angina is pain, "discomfort," or pressure localized in the chest that is caused by an insufficient supply of blood (ischemia) to the heart muscle.
 received only tamoxifen.

Using ultrasound, physicians then measured artery dilation dilation /di·la·tion/ (di-la´shun)
1. the act of dilating or stretching.

2. dilatation.


di·la·tion
n.
1.
, the percentage by which a coronary artery expands with each beat of the heart. In the heart patients getting tamoxifen, average dilation improved from 2.1 percent per beat at the start of the study to 7.5 percent at the end, the researchers report in the March 20 CIRCULATION. In the patients getting the placebo, dilation remained unchanged at 2.1 percent. Dilation in the men with angina who took tamoxifen rose during the study from 3.8 percent to 7.9 percent per beat.

Increased dilation facilitates blood flow and eases the risk of heart attack. Men have an average coronary artery dilation of 7 percent until age 40. This drops to about 5 percent by age 51 and to 3.5 percent around age 63, says study coauthor James C. Metcalfe of the University of Cambridge in England. The figures are lower for men with heart disease.

The men getting tamoxifen also saw significant reductions in blood concentrations of fibrinogen Fibrinogen

The major clot-forming substrate in the blood plasma of vertebrates. Though fibrinogen represents a small fraction of plasma proteins (normal human plasma has a fibrinogen content of 2–4 mg/ml of a total of 70 mg protein/ml), its conversion
, a blood-clotting compound.
COPYRIGHT 2001 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:use of breast cancer drug may aid heart disease
Publication:Science News
Article Type:Brief Article
Geographic Code:1USA
Date:May 5, 2001
Words:269
Previous Article:Long-term ecstasy use impairs memory.(Brief Article)
Next Article:The Latest Pisces of an Evolutionary Puzzle.(discovery of coelacanth off coast of South Africa)
Topics:



Related Articles
Preventive tamoxifen: safe so far. (as a means of preventing breast cancer)
Tamoxifen trial begins amid new concerns. (Brief Article)
Tamoxifen use limited. (National Surgical Adjuvant Breast and Bowel Project research results indicate tamoxifen ineffective or harmful in breast...
Tamoxifen therapy should last 5 years. (risks of uterine cancer may outweigh benefit of Tamoxifen after 5 years)(Biomedicine)(Brief Article)
Drug prevents some cancer, poses risks.(tamoxifen)(Brief Article)
Tamoxifen may not prevent breast cancer.(Brief Article)
Designer Estrogens.(research on synthetic hormones)
Drugs tested for Lou Gehrig's disease. (Biomedicine).(tamoxifen, celecoxib)(Brief Article)
Selective estrogen receptor modulators. (Featured CME Topic).(medical research; includes tables)
Two drugs are equal in preventing breast cancer.(BIOMEDICINE)(raloxifene (Evista) with tamoxifen (Nolvadex) )(Brief article)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles